Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia … (NCT05890690) | Clinical Trial Compass
CompletedNot Applicable
Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome
Switzerland48 participantsStarted 2023-06-02
Plain-language summary
The aim of this study is to investigate whether oral urea stimulates copeptin release and, if so, whether it may provide a novel diagnostic test in the differentiation between AVP-D (Arginine vasopressin deficiency) and PP (primary polydipsia).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Healthy volunteers
Inclusion Criteria:
* Age ≥18 years
* Healthy with no medication except hormonal contraception
Exclusion Criteria:
* Participation in a trial with investigational drugs within 30 days
* Evidence of disordered drinking habits and diuresis defined as polyuria \>50ml/kg body weight/24h and polydipsia \>3l /24h
* Known allergy towards components of the study drink
* Pregnancy and breastfeeding
* Intention to become pregnant during the study
* Evidence of acute illness
Patients
Inclusion Criteria:
* Age ≥ 18 years
* Documented PP or AVP-D based on accepted diagnostic criteria, i.e., water deprivation test, hypertonic saline infusion test or arginine infusion test. Accordingly, patients must have evidence of disordered drinking habits and diuresis defined as polyuria \>50ml/kg body weight/24h and polydipsia \>3l /24h or must be on regular daily desmopressin medication
Exclusion Criteria:
* Participation in a trial with investigational drugs within 30 days
* Known allergy towards components of the study drink
* Pregnancy and breastfeeding
* Evidence of acute illness
What they're measuring
1
Difference in maximal increase in copeptin levels in plasma (pmol/l)
Timeframe: up to 6 time assessment until 150 minutes after baseline